Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $23.00M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KALA | KALA BIO INC | $9.94M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ACXP | ACURX PHARMACEUTICALS INC | $7.21M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ATYR | ATYR PHARMA INC | $68.98M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MRSN | MERSANA THERAPEUTICS INC | $41.32M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GOVX | GEOVAX LABS INC | $14.71M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $81.60M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FGEN | FIBROGEN INC | $47.43M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NRXP | NRX PHARMACEUTICALS INC | $64.44M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SGMO | SANGAMO THERAPEUTICS INC | $206.07M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GRI | GRI BIO INC | $4.80M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FEMY | FEMASYS INC | $17.16M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PSTV | PLUS THERAPEUTICS INC | $72.46M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.83M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.29M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.19M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LSTA | LISATA THERAPEUTICS INC | $21.67M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MDCX | MEDICUS PHARMA LTD | $45.25M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MTVA | METAVIA INC | $24.92M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CING | CINGULATE INC | $22.62M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MBRX | MOLECULIN BIOTECH INC | $13.99M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.36M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SLN | SILENCE THERAPEUTICS PLC | $235.93M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| CRDL | CARDIOL THERAPEUTICS INC | $88.46M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MYO | MYOMO INC | $35.95M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JSPR | JASPER THERAPEUTICS INC | $40.47M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INTS | INTENSITY THERAPEUTICS INC | $13.18M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PASG | PASSAGE BIO INC | $25.27M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NOTE | FISCALNOTE HOLDINGS INC | $74.05M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IMUX | IMMUNIC INC | $93.71M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PMN | PROMIS NEUROSCIENCES INC | $25.90M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TIL | INSTIL BIO INC | $122.19M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $12.05M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ACET | ADICET BIO INC | $69.06M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $14.63M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ANVS | ANNOVIS BIO INC | $43.26M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $295.10M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.